- Investing Ideas
- Swiss Pharmaceuticals & Biotech Blue chip stocks
Swiss Pharmaceuticals & Biotech Blue chip stocks
Results
3
0 new
3 companies
Lonza Group
Market Cap: CHF 34.6b
Operates as a contract development and manufacturing organization for pharma and biotech companies in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally.
LONN
CHF 494.40
7D
-0.2%
1Y
-11.7%
Galderma Group
Market Cap: CHF 40.6b
Operates as a dermatology company worldwide.
GALD
CHF 171.25
7D
3.5%
1Y
58.4%
Sandoz Group
Market Cap: CHF 29.0b
Develops, manufactures, and markets generic and biosimilars worldwide.
SDZ
CHF 66.82
7D
3.4%
1Y
57.6%